A next-generation, live-attenuated yellow fever vaccine, vYF, was developed in Vero cells to improve vaccine supply and availability. The safety of and immune response to vYF as compared with those of ...

Yellow fever outbreaks in recent years and subsequent vaccine shortages have highlighted a need for updated shots that can be produced more rapidly. To help speed production, an investigational ...

Yellow fever is a viral disease that is spread to humans through the bites of infected mosquitoes. The symptoms range from mild fever-like aches and pains to severe liver disease with bleeding, often ...

An investigational yellow fever vaccine (vYF) that could help avoid shortages matched the immunogenicity and safety profile of the FDA-approved shot (YF-VAX), according to a phase II trial. In healthy ...

To help ensure a sufficient supply of yellow fever vaccine, a next-generation, live-attenuated vaccine — vYF — has been developed. New research findings on its safety and immunogenicity are summarized ...